Latitude Food Group (LFG), franchisor and operator of &pizza and Tijuana Flats, today announced a refreshed, protein‑forward ...

Health treatments containing GLP-1 have been used succesfully to fight diabetes, obesity and a number of other conditions ...

Gypsy Rose Blanchard shares how life after prison led to her weight loss with home cooked meals, lifestyle shifts and not using GLP-1s ...

The FDA issued warning letters to 30 telehealth companies over misleading claims about compounded versions of popular ...

1. FDA. FDA Warns 30 Telehealth Companies Against Illegal Marketing of Compounded GLP-1s. FDA News Release. March 3, 2026.

A new survey suggests about three million Canadian adults are currently taking GLP-1 drugs such as Ozempic or Mounjaro and ...

Results showed that use of GLP-1 receptor agonists did not increase short-term medical or surgical complications among ...

FDA sends Novo Nordisk 2nd warning over GLP-1 ads for misleading claims in Ozempic promotion and risk disclosure violations.

GLP-1 drugs like semaglutide (Ozempic and Wegovy) have finally started to make weight loss a sustainable reality for many ...

Research led by Penn Dental's Henry Daniell investigates the use of a lettuce-based, plant-encapsulated delivery platform as ...

Obesity dipped in Minnesota as GLP‑1 use rose. Experts warn the long‑term picture and who pays are still unsettled.

A few months into GLP-1 treatment, many patients encounter an unexpected and distressing side effect: significant hair loss.